Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation

被引:14
作者
Moser, CA
Speaker, TJ
Berlin, JA
Offit, PA
机构
[1] CHILDRENS HOSP,INFECT DIS SECT,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,ABRAMSON CTR,PHILADELPHIA,PA 19104
[3] TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19140
[4] UNIV PENN,SCH MED,CTR CLIN EPIDEMIOL & BIOSTAT,PHILADELPHIA,PA 19104
[5] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
关键词
microencapsulation; adjuvants; rotavirus;
D O I
10.1016/S0264-410X(96)00026-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccines are commonly administered by the parenteral route. Therefore, adjuvant strategies which include parenteral immunization may improve the efficacy of a number of current vaccines. The capacity of aqueous-based microencapsulation to enhance virus-specific IgG responses in mice inoculated intramuscularly with small quantities of antigen was evaluated Mice were inoculated with either 10(4), 10(3), or 10(2) p.f.u. of microencapsulated rotavirus (bovine strain WC3), placebo microcapsules plus free virus, or virus alone. Mice were subsequently bled 1, 2, 4, 6, and 9 months after inoculation. Microencapsulation of rotavirus enhanced virus-specific humoral immune responses. In addition, virus-containing microcapsules composed of spermine-chondroitin sulfate induced levels of virus-specific antibodies greater than those found after inoculation with virus-containing microcapsules composed of spermine-alginate. Mechanisms by which microencapsulation may enhance virus-specific humoral immunity are discussed. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:1235 / 1238
页数:4
相关论文
共 15 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   ENHANCEMENT BY MICROENCAPSULATION OF ROTAVIRUS-SPECIFIC INTESTINAL IMMUNE-RESPONSES IN MICE ASSESSED BY ENZYME-LINKED IMMUNOSPOT ASSAY AND INTESTINAL FRAGMENT CULTURE [J].
BROWN, KA ;
MOSER, CA ;
SPEAKER, TJ ;
KHOURY, CA ;
KIM, JE ;
OFFIT, PA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1334-1338
[3]   THE ISCOM STRUCTURE AS AN IMMUNE-ENHANCING MOIETY - EXPERIENCE WITH VIRAL SYSTEMS [J].
CLAASSEN, I ;
OSTERHAUS, A .
RESEARCH IN IMMUNOLOGY, 1992, 143 (05) :531-541
[4]   IMMUNE-RESPONSE OF INFANTS AND CHILDREN TO LOW-PASSAGE BOVINE ROTAVIRUS (STRAIN WC3) [J].
CLARK, HF ;
FURUKAWA, T ;
BELL, LM ;
OFFIT, PA ;
PERRELLA, PA ;
PLOTKIN, SA .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (04) :350-356
[5]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[6]   BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
MCGHEE, JR ;
TICE, TR ;
GILLEY, RM .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :287-294
[7]  
GOULDFOGERITE S, 1992, LIPOSOME TECHNOLOGY, V3
[8]   ORAL INOCULATION OF MICE WITH LOW-DOSES OF MICROENCAPSULATED, NONINFECTIOUS ROTAVIRUS INDUCES VIRUS-SPECIFIC ANTIBODIES IN GUT-ASSOCIATED LYMPHOID-TISSUE [J].
KHOURY, CA ;
MOSER, CA ;
SPEAKER, TJ ;
OFFIT, PA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :870-874
[9]   VACCINATION OF RHESUS-MONKEYS WITH SYNTHETIC PEPTIDE IN A FUSOGENIC PROTEOLIPOSOME ELICITS SIMIAN IMMUNODEFICIENCY VIRUS-SPECIFIC CD8+ CYTOTOXIC LYMPHOCYTES-T [J].
MILLER, MD ;
GOULDFOGERITE, S ;
SHEN, L ;
WOODS, RM ;
KOENIG, S ;
MANNINO, RJ ;
LETVIN, NL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1739-1744
[10]   ORAL IMMUNIZATION WITH INFLUENZA-VIRUS IN BIODEGRADABLE MICROSPHERES [J].
MOLDOVEANU, Z ;
NOVAK, M ;
HUANG, WQ ;
GILLEY, RM ;
STAAS, JK ;
SCHAFER, D ;
COMPANS, RW ;
MESTECKY, J .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :84-90